Arbour Group Highlights 2012 Regulatory Trends for Life Sciences Companies
(firmenpresse) - CHICAGO, IL -- (Marketwire) -- 02/21/12 -- Arbour Group, a leading provider of regulatory products and services for life sciences organizations, has summarized its perspective as to regulatory compliance trends for 2012 based on feedback from customers. Even though there are increased signs of recovery for the economy as a whole, budgets for Information Technology and Regulatory Compliance for life sciences companies continue to be scrutinized to ensure funds are spent on priority initiatives and support overall company strategies related to growth, cost effectiveness and sustainability.
The key trends projected for 2012 include (1) high growth for the medical device segment as the proliferation of surgical, medical equipment and personal care solutions continues, (2) increased use of compliance analytics to provide usable and timely information reporting for post-market surveillance, DEA suspicious orders, aggregate spend, Risk Evaluation & Mitigation Strategies (REMS) etc., (3) tighter surveillance of supplier performance as the use of contract manufacturers, third-party logistics providers and software developers (including SaaS) enjoy greater acceptance and (4) continued adoption of mobile devices.
Arbour Group continues to respond to these emerging trends with expanded offerings in the following areas:
510(k) Validation & Verification
Compliance Analytics Reporting Services
Supplier Control Programs
Mobile Medical Applications Testing
In addition to the above, Arbour Group continues to provide software compliance packages, regulatory project management and professional validation services as well as outsourced compliance solutions.
"Our customers must respond to the regulatory challenges presented by a continuously evolving supply chain," stated Alexander Patterson, President and CEO of Arbour Group. "Arbour Group can provide the global regulatory expertise required to respond quickly and effectively in a dynamic environment."
Arbour Group LLC is a leading provider of global regulatory products and services for pharmaceutical, medical device and biotechnology companies worldwide.
Arbour Group's regulatory products include packaged validation protocols that help clients ensure that key enterprise software solutions are functional and in compliance with applicable regulations to minimize business risk. Regulatory services are based on a results-oriented software testing process that not only assures compliance and functionality, but also supports product quality and reliability.
Arbour Group has been lowering the cost of compliance since 1990 for over 200 multinational companies with a global presence including United States offices in California, Illinois, Massachusetts and New Jersey, along with facilities in Dublin, Ireland, Dubai, U.A.E. and Manila, Philippines.
All trade names, trademarks, and service marks are the rightful property of their respective owners.
For more information, contact Arbour Group at .
Arbour Group
One Parkview Plaza
Suite 660
Oakbrook Terrace, IL 60181
Phone 312.207.5800
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 21.02.2012 - 13:00 Uhr
Sprache: Deutsch
News-ID 116637
Anzahl Zeichen: 0
contact information:
Town:
CHICAGO, IL
Kategorie:
Software
Diese Pressemitteilung wurde bisher 248 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Arbour Group Highlights 2012 Regulatory Trends for Life Sciences Companies"
steht unter der journalistisch-redaktionellen Verantwortung von
Arbour Group (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
